Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
September 24, 2024 08:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...
Partnership for a Drug-Free New Jersey Recognized with Multiple Jersey Awards
September 23, 2024 10:35 ET
|
Partnership for a Drug-Free New Jersey
Cedar Grove, NJ, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Partnership for a Drug-Free New Jersey (PDFNJ) earned recognition for its efforts to tackle the opioid crisis, earning three first-place...
Webinar to Commemorate Statewide Knock Out Opioid Abuse Day
September 19, 2024 10:40 ET
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The ninth webinar in the 2024 Knock Out Opioid Abuse Day Learning Series will outline the latest developments in the nationwide opioid epidemic. This...
Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial
September 15, 2024 08:45 ET
|
Genmab A/S
Media ReleaseCOPENHAGEN, Denmark; September 15, 2024 Treatment with rinatabart sesutecan (Rina-S) showed encouraging response rate in heavily pretreated patients with ovarian cancer in dose expansion...
Magnificat Houses, Inc. – A Light Beyond the Streets: Rose Mary Badami’s Legacy of Love, Dignity, and Community
September 13, 2024 12:23 ET
|
Magnificat Houses
Houston, Texas, Sept. 13, 2024 (GLOBE NEWSWIRE) -- At the heart of Magnificat Houses, Inc. (MHI) lies the belief that a dignified life is a right, not a luxury. On a mission to instill a sense of...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
September 10, 2024 16:06 ET
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; September 10, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The...
New Jersey Unites Against a Crisis: Ninth Annual Knock Out Opioid Abuse Day Set for October 6
September 04, 2024 10:35 ET
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Sept. 04, 2024 (GLOBE NEWSWIRE) -- New Jersey is presenting a united front against the opioid epidemic as communities across the state gear up for the ninth annual Knock Out Opioid...
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024 12:26 ET
|
Genmab A/S
Media ReleaseCOPENHAGEN, Denmark; August 26, 2024 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano will...
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
August 19, 2024 14:00 ET
|
Genmab A/S
Company Announcement TEPKINLY is the first and only subcutaneous bispecific antibody approved as a monotherapy in the European Union to treat both relapsed or refractory (R/R) follicular lymphoma...
Induced Pluripotent Stem Cell (iPSC) Global Industry Report 2024 - Revolutionizing Medicine: The Transformative Power and Commercial Potential of Induced Pluripotent Stem Cells (iPSCs)
August 16, 2024 10:44 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2024" report has been added to ResearchAndMarkets.com's...